Skip to main content
EJNMMI Research
Figure 5 | EJNMMI Research

Figure 5

From: A 90Y-labelled anti-ROBO1 monoclonal antibody exhibits antitumour activity against hepatocellular carcinoma xenografts during ROBO1-targeted radioimmunotherapy

Figure 5

Histological analysis of tumours. (a) HepG2 tumour on day 0, original magnification × 400; (b) HepG2 tumour on day 7, original magnification × 400; (c) HepG2 tumour on day 14, original magnification × 400; (d) HepG2 tumour on day 28, original magnification × 400. Scale bar = 100 μm.

Back to article page